Cargando…
Imaging Changes and Immune-Checkpoint Expression on T Cells in Bronchoalveolar Lavage Fluid from Patients with Pulmonary Sarcoidosis
Sarcoidosis is a systemic, granulomatous disease caused by unknown immunological abnormalities. The organs most vulnerable to sarcoidosis are the lungs. Patients often resolve spontaneously, but the lungs can also be severely affected. Although details regarding prognostic factors in sarcoidosis pat...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471595/ https://www.ncbi.nlm.nih.gov/pubmed/34572417 http://dx.doi.org/10.3390/biomedicines9091231 |
_version_ | 1784574507681316864 |
---|---|
author | Kotetsu, Yasuaki Yanagihara, Toyoshi Suzuki, Kunihiro Ando, Hiroyuki Eto, Daisuke Hata, Kentaro Arimura-Omori, Masako Yamamoto, Yuzo Harada, Eiji Hamada, Naoki |
author_facet | Kotetsu, Yasuaki Yanagihara, Toyoshi Suzuki, Kunihiro Ando, Hiroyuki Eto, Daisuke Hata, Kentaro Arimura-Omori, Masako Yamamoto, Yuzo Harada, Eiji Hamada, Naoki |
author_sort | Kotetsu, Yasuaki |
collection | PubMed |
description | Sarcoidosis is a systemic, granulomatous disease caused by unknown immunological abnormalities. The organs most vulnerable to sarcoidosis are the lungs. Patients often resolve spontaneously, but the lungs can also be severely affected. Although details regarding prognostic factors in sarcoidosis patients with lung involvement remain unclear, several reports have suggested that immune checkpoint molecules are involved in the pathogenesis of sarcoidosis. In this study, we divided sarcoidosis patients into two groups based on chest computed tomography (CT) findings and compared immune checkpoint molecules expressed on T cells in bronchoalveolar lavage fluid (BALF) in the two groups, using flow cytometry. We found elevated programmed cell death 1 (PD-1) or T cell immunoglobulin- and mucin-domain-containing molecule-3 (TIM-3) expression on T cells in BALF in patients with spontaneous improvement in CT findings, compared with those in patients without improvement in CT findings. In conclusion, our study implies that PD-1 or TIM-3 expression on T cells in BALF may be a prognostic factor for pulmonary lesions in sarcoidosis. |
format | Online Article Text |
id | pubmed-8471595 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84715952021-09-28 Imaging Changes and Immune-Checkpoint Expression on T Cells in Bronchoalveolar Lavage Fluid from Patients with Pulmonary Sarcoidosis Kotetsu, Yasuaki Yanagihara, Toyoshi Suzuki, Kunihiro Ando, Hiroyuki Eto, Daisuke Hata, Kentaro Arimura-Omori, Masako Yamamoto, Yuzo Harada, Eiji Hamada, Naoki Biomedicines Article Sarcoidosis is a systemic, granulomatous disease caused by unknown immunological abnormalities. The organs most vulnerable to sarcoidosis are the lungs. Patients often resolve spontaneously, but the lungs can also be severely affected. Although details regarding prognostic factors in sarcoidosis patients with lung involvement remain unclear, several reports have suggested that immune checkpoint molecules are involved in the pathogenesis of sarcoidosis. In this study, we divided sarcoidosis patients into two groups based on chest computed tomography (CT) findings and compared immune checkpoint molecules expressed on T cells in bronchoalveolar lavage fluid (BALF) in the two groups, using flow cytometry. We found elevated programmed cell death 1 (PD-1) or T cell immunoglobulin- and mucin-domain-containing molecule-3 (TIM-3) expression on T cells in BALF in patients with spontaneous improvement in CT findings, compared with those in patients without improvement in CT findings. In conclusion, our study implies that PD-1 or TIM-3 expression on T cells in BALF may be a prognostic factor for pulmonary lesions in sarcoidosis. MDPI 2021-09-16 /pmc/articles/PMC8471595/ /pubmed/34572417 http://dx.doi.org/10.3390/biomedicines9091231 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kotetsu, Yasuaki Yanagihara, Toyoshi Suzuki, Kunihiro Ando, Hiroyuki Eto, Daisuke Hata, Kentaro Arimura-Omori, Masako Yamamoto, Yuzo Harada, Eiji Hamada, Naoki Imaging Changes and Immune-Checkpoint Expression on T Cells in Bronchoalveolar Lavage Fluid from Patients with Pulmonary Sarcoidosis |
title | Imaging Changes and Immune-Checkpoint Expression on T Cells in Bronchoalveolar Lavage Fluid from Patients with Pulmonary Sarcoidosis |
title_full | Imaging Changes and Immune-Checkpoint Expression on T Cells in Bronchoalveolar Lavage Fluid from Patients with Pulmonary Sarcoidosis |
title_fullStr | Imaging Changes and Immune-Checkpoint Expression on T Cells in Bronchoalveolar Lavage Fluid from Patients with Pulmonary Sarcoidosis |
title_full_unstemmed | Imaging Changes and Immune-Checkpoint Expression on T Cells in Bronchoalveolar Lavage Fluid from Patients with Pulmonary Sarcoidosis |
title_short | Imaging Changes and Immune-Checkpoint Expression on T Cells in Bronchoalveolar Lavage Fluid from Patients with Pulmonary Sarcoidosis |
title_sort | imaging changes and immune-checkpoint expression on t cells in bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471595/ https://www.ncbi.nlm.nih.gov/pubmed/34572417 http://dx.doi.org/10.3390/biomedicines9091231 |
work_keys_str_mv | AT kotetsuyasuaki imagingchangesandimmunecheckpointexpressionontcellsinbronchoalveolarlavagefluidfrompatientswithpulmonarysarcoidosis AT yanagiharatoyoshi imagingchangesandimmunecheckpointexpressionontcellsinbronchoalveolarlavagefluidfrompatientswithpulmonarysarcoidosis AT suzukikunihiro imagingchangesandimmunecheckpointexpressionontcellsinbronchoalveolarlavagefluidfrompatientswithpulmonarysarcoidosis AT andohiroyuki imagingchangesandimmunecheckpointexpressionontcellsinbronchoalveolarlavagefluidfrompatientswithpulmonarysarcoidosis AT etodaisuke imagingchangesandimmunecheckpointexpressionontcellsinbronchoalveolarlavagefluidfrompatientswithpulmonarysarcoidosis AT hatakentaro imagingchangesandimmunecheckpointexpressionontcellsinbronchoalveolarlavagefluidfrompatientswithpulmonarysarcoidosis AT arimuraomorimasako imagingchangesandimmunecheckpointexpressionontcellsinbronchoalveolarlavagefluidfrompatientswithpulmonarysarcoidosis AT yamamotoyuzo imagingchangesandimmunecheckpointexpressionontcellsinbronchoalveolarlavagefluidfrompatientswithpulmonarysarcoidosis AT haradaeiji imagingchangesandimmunecheckpointexpressionontcellsinbronchoalveolarlavagefluidfrompatientswithpulmonarysarcoidosis AT hamadanaoki imagingchangesandimmunecheckpointexpressionontcellsinbronchoalveolarlavagefluidfrompatientswithpulmonarysarcoidosis |